JIREJPMorgan International Research Enhanced Equity ETF
Seeks long-term capital appreciation.
By JPMorgan · Launched 1992
Annual Cost
0.24%
#1,152 of 5,562 · low cost
Fund Size
$10.9B
#254 of 5,562 · large
Return (1Y)Goal
+23.7%
Track Record
33 years
#8 of 5,562 · established
Performance
Total-return NAV · USDGrowth of $10,000
$12,343+23.4%
Total-return NAV, USD. Net of fund fees, before tax.
Classification
How Beacon categorizes this fundWhat it actually holds
By weightConcentration
Top 10 holdings = 17.1% of fund✓ well diversified
ASML Holding NV
3.2%
AstraZeneca plc
2.0%
Shell plc
1.7%
Siemens AG
1.7%
Banco Santander SA
1.6%
Roche Holding AG
1.4%
Allianz SE
1.4%
HSBC Holdings plc
1.4%
Nestle SA
1.3%
UniCredit SpA
1.3%
Asset allocation
Stocks
99.3%
Cash
0.5%
Other
0.3%
By sector
Financial Services
25.7%
Industrials
18.5%
Technology
12.2%
Healthcare
10.1%
Consumer Cyclical
8.3%
Consumer Defensive
6.6%
Basic Materials
5.4%
Communication
4.4%
Other
8.6%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
16.0%Moderate
Year-on-year price swings
Max drawdown
-16.1%Moderate
Worst peak-to-trough loss
Sharpe (3Y)
0.83Decent risk-adjusted returns
Sortino (3Y)
1.22Good downside protection
Where to buy
Listing
- Exchange
- NYSE Arca
Full fund details
- Objective
- Seeks long-term capital appreciation.
- Strategy
- Invests primarily in equity securities of foreign companies across various market capitalizations, aiming to outperform the MSCI EAFE Index. The Fund emphasizes undervalued securities while managing risk through diversification across developed markets.
- Inception date
- October 28, 1992
- Fund family
- JPMorgan
Similar ETFs
Closest matches by profileWhat's next?
You've reviewed JIRE. Save it to your watchlist to track it alongside the other funds you're weighing.
Data updated on 2026-06-19